Astellas Pharma Inc.TSE 4503

アステラス製薬株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥2,527
FY ending Mar 2026
Market cap at FY-end
¥4.57T
Dividend per share
¥78.0
Avg. director pay
¥259M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 日本マスタートラスト信託銀行株式会社 343,200,000 18.96% ¥867B ¥26.8B
2 株式会社日本カストディ銀行 130,182,000 7.19% ¥329B ¥10.2B
3 日本生命保険相互会社 51,588,000 2.85% ¥130B ¥4.0B
4 STATE STREET BANK AND TRUST COMPANY 505001 38,405,000 2.12% ¥97.1B ¥3.0B
5 JPモルガン証券株式会社 30,057,000 1.66% ¥76.0B ¥2.3B
6 JP MORGAN CHASE BANK 385781 26,465,000 1.46% ¥66.9B ¥2.1B
7 SMBC日興証券株式会社 22,484,000 1.24% ¥56.8B ¥1.8B
8 野村信託銀行株式会社 22,218,000 1.22% ¥56.2B ¥1.7B
9 STATE STREET BANK AND TRUST COMPANY 505103 21,360,000 1.18% ¥54.0B ¥1.7B

Officers' holdings and pay

NameTitleSharesValuePay
Kenji Yasukawa Chairman & Representative Director 245,000 ¥619M —
岡村 直樹 President & Representative Director 84,000 ¥212M —
杉田 勝好 Executive Vice President & Representative Director 11,000 ¥27.8M —
田中 孝司 Director — — —
桜井 恵理子 Director — — —
宮﨑 正啓 Director 8,000 ¥20.2M —
大野 洋一 Director — — —
Mark Enyedy Director — — —
廣田 里香 Director (Audit & Supervisory Committee Member) 9,000 ¥22.7M —
中山 美加 Director (Audit & Supervisory Committee Member) — — —
秋山 里絵 Director (Audit & Supervisory Committee Member) — — —
荒牧 知子 Director (Audit & Supervisory Committee Member) — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥2,527 ¥205.47 12.3x ¥78.0 1,809,663,000
FY ending Mar 2025 ¥1,447 ¥178.59 8.1x ¥74.0 1,809,663,000
FY ending Mar 2024 ¥1,646 ¥162.92 10.1x ¥70.0 1,809,663,000
Source: annual securities reports on EDINET. Values are estimates. Methodology